Cellular Biomedicine (CBMG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -42,118 | -25,080 | -11,548 | -49,984 | -37,297 |
| Depreciation Amortization | 4,850 | 3,158 | 1,593 | 5,638 | 4,099 |
| Accounts receivable | -32 | N/A | N/A | 1 | 1 |
| Accounts payable and accrued liabilities | 1,021 | -210 | -744 | 1,171 | 4,695 |
| Other Working Capital | 1,161 | 59 | -516 | 611 | 1,695 |
| Other Operating Activity | 1,947 | 2,255 | 1,920 | 2,913 | -1,554 |
| Operating Cash Flow | $-33,170 | $-19,817 | $-9,295 | $-39,650 | $-28,361 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -7,057 | -4,483 | -1,583 | -10,675 | -8,646 |
| Purchase Sale Intangibles | -176 | -142 | -52 | -869 | -804 |
| Other Investing Activity | -176 | -142 | -52 | -721 | -632 |
| Investing Cash Flow | $-7,233 | $-4,625 | $-1,634 | $-11,396 | $-9,278 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 47,852 | 19,456 | 14,000 | 14,546 | 14,546 |
| Common Stock Issued | 526 | 482 | 482 | 17,450 | 17,362 |
| Common Stock Repurchased | N/A | N/A | N/A | -1,039 | -1,039 |
| Other Financing Activity | -14,316 | -14,316 | -14,316 | -471 | 0 |
| Financing Cash Flow | $34,062 | $5,623 | $166 | $30,486 | $30,869 |
| Exchange Rate Effect | -73 | -42 | -84 | 190 | -7 |
| Beginning Cash Position | 32,444 | 32,444 | 32,444 | 52,813 | 52,813 |
| End Cash Position | 26,029 | 13,582 | 21,597 | 32,444 | 46,036 |
| Net Cash Flow | $-6,415 | $-18,862 | $-10,846 | $-20,369 | $-6,777 |
| Free Cash Flow | |||||
| Operating Cash Flow | -33,170 | -19,817 | -9,295 | -39,650 | -28,361 |
| Capital Expenditure | -7,057 | -4,483 | -1,583 | -10,675 | -8,646 |
| Free Cash Flow | -40,228 | -24,301 | -10,877 | -50,325 | -37,007 |